Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.South Korea |
First Approval Date20 Feb 2026 |
100 Clinical Results associated with Korea Vaccine Co., Ltd.
0 Patents (Medical) associated with Korea Vaccine Co., Ltd.
100 Deals associated with Korea Vaccine Co., Ltd.
100 Translational Medicine associated with Korea Vaccine Co., Ltd.